申请人:Giblin Paul Gerard Martin
公开号:US20060252799A1
公开(公告)日:2006-11-09
The present invention relates to compounds of formula (I)
and pharmaceutically acceptable derivatives thereof, which bind with high affinity to the EP4 receptor and are of use in the treatment or prevention of conditions such as a pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.
本发明涉及式(I)化合物及其药学上可接受的衍生物,它们具有高亲和力与EP4受体结合,可用于治疗或预防疼痛、炎症、免疫、骨骼、神经退行性或肾脏疾病等情况。